ChemoCentryx, Inc. (CCXI) Q2 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to the Chemo Centrics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. As a reminder, this conference call will be recorded. I would now like to turn the call over to Lee Roth of Burns McLean. Mr. Roth, please go ahead. Thank you, Paul. Good afternoon, and welcome to the Chemocentric second quarter 2021 financial results conference call. Earlier today, the company issued a press release providing an overview of its financial results for the quarter ended June 30th, 2021. And a copy of this release, along with a few slides that you may find helpful while you listen to the call, are available on the investor relations section of our website at www.chemocentrics.com. Joining us on the call today is Dr. Thomas Shaw, President and Chief Executive Officer of Chemocentrics, who will review the company's recent business and clinical progress. Following his comments, Susan Kanaya, Executive Vice President, Chief Financial and Administrative Officer, will provide an overview of the company's financial highlights for the quarter before turning the call back over to Tom for closing remarks. Tasif Tashbat, Executive Vice President and Chief Operating Officer, will then join Tom and Susan for Q&A sessions. During today's call, we'll be making certain forward-looking statements. As explained on slide two of the presentation, these forward-looking statements are based on current information, assumptions, and expectations that are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These risks are described in the company'...